narrowly missed significancep = 0.06
IC2/3 narrowly missed significance for OS in this cohort (HR = 0.53 p = 0.06).
IC2/3 narrowly missed significance for OS in this cohort (HR = 0.53 p = 0.06).
Unfortunately, a Phase 3 confirmatory study, IMvigor211 ( NCT02302807 ), using the primary endpoint of OS where patients with IC2/3 status were tested first in a hierarchical sequence, failed to reach significance [ 9 ].